Erlander Mark 4
4 · Cardiff Oncology, Inc. · Filed May 18, 2020
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2020-05-14$1.43/sh+6,993$10,000→ 13,369 total
4 · Cardiff Oncology, Inc. · Filed May 18, 2020
Common Stock